Zadno Reza 4
4 · PROCEPT BioRobotics Corp · Filed Oct 31, 2024
Insider Transaction Report
Form 4
Zadno Reza
DirectorPresident, CEO
Transactions
- Sale
Common Stock
2024-10-30$91.00/sh−288,461$26,249,951→ 258,445 total - Exercise/Conversion
Common Stock
2024-10-30$4.37/sh+288,461$1,260,575→ 546,906 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-30−288,461→ 961,148 totalExercise: $4.37Exp: 2030-02-19→ Common Stock (288,461 underlying)
Footnotes (2)
- [F1]Shares sold on October 30, 2024, pursuant to the underwriters exercise of an option to purchase shares as detailed in the prospectus supplement filed with the SEC, dated October 29, 2024, pursuant to Rule 424(b)(5) and Registration No. 333-273569.
- [F2]The Stock option was granted on February 20, 2020, and vested over a four year period.